The method taken as a principle of technology is based on the detection in surveyed whey fibers or polypeptides with changed chemical, and-or physical properties which are synthesized by tumoral cages from the beginning of their origination.
Interacting with these fibers of special reagents and affecting on light response of certain power and spectrum leads to change of optical density of investigated whey in comparison with the control which is the whey of the same surveyed, but without reagents.
Response reading is carried out at the expense of whey scanning over the range a visible spectrum (360 – 600 nanometers). Thus, the effect of scanning of the control uses as a zero line. Spectrograms of oncological patients have the characteristic peaks of optical density corresponding to the anomalous fibers, reacted with reagents.
These pathological fibers can be different in different patients and at different swellings (this theme is the future design subject), however they, reacting with certain reagents come to light at scanning over the range a visible spectrum.
At healthy people these fibers miss, that allows to use the given method for early preliminary treatment of patients with oncological diseases, irrespective of origination place and a swelling morphological structure.